2017 Scientific Frontiers

The following were presented at Probitoa 2017 based on abstracts submitted to the Scientific Frontiers session and reviewed by the Scientific Committee

Download full abstracts

Oral presentations

The IMPRINT (Infant Microbiota and Probiotic Intake) study: Microbiome remodeling in breast-fed infants following supplementation with a keystone Bifidobacterium species
Dr Steven Frese, Evolve Biosystems

An assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum LP-LDL in adults with normal to mildly elevated cholesterol
Stephen OHara, Optibiotix Health


1 – In vitro and in vivo selection of probiotic strains with beneficial properties in IBD and obesity
Angèle Guilbot, PILEJE

2 – Faecalibacterium prausnitzii exhibits antinociceptive effect in a non-inflammatory visceral IBS-like pain model
Prof Denis Ardid, UMR1107 NEURO-DOL Inserm/UdA

3 – Potential effect of a synbiotic diet dessert containing Lactobacillus acidophilus La-5 on hematological parameters in patients with metabolic syndrome
Douglas Xavier dos Santos, University of Sao Paulo

4 – Development of a synergistic synbiotic for Lactobacillus plantarum LP-LDL targeting cholesterol reduction
Dr Sofia Kolida,  OptiBiotix Health

5 – Elucidating microbiome-host communication: Ferulic acid is a cross-talk mediator between L. fermentum NCIMB 5221 and the host metabolic, anti-oxidant and immune systems
Susan Westfall, McGill University

6 – Survey of the knowledge of Swiss Family Doc’s on microbiota and probiotics
Dr Bianca-Maria Exl-Preysch, Exl-lent Nutrition Consultants

7 – Effect of Agaricus bisporus mushroom consumption on gastrointestinal tolerance and breath hydrogen response in healthy human subjects
Julie Hess, University of Minnesota

8 – Simulating colonic survival of probiotics in single strain products as compared to multi-strain products
Krista Salli, DuPont Nutrition and Health

9 – CoMiniGut– a small volume in vitro colon model with increased throughput
Dr Maria Wiese, University of Copenhagen

10 – Prebiotic modulation of the gut microbiota by a fermentate from yeast and its effect in humans on digestive comfort and stool parameters
Dr Massimo Marzorati, ProDigest

11 – TSI – a low volume small intestine model with increased throughput
Tomas Cieplak, University of Copenhagen

12 – An assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum LP-LDL in adults with normal to mildly elevated cholesterol
Stephen OHara, OptiBiotix Health

13 – Effect of bacterial lysates obtained from Lactobacillus spp. on THP-1 cells
Erica Castro Inostroza, Universidad San Sebastián

14 – Probiotic characteristics of Lactobacillus plantarum LRCC5193 isolated from kimchi and its potential application in dairy chocolate
Miri Park, Lotte R&D Center

15 – Laxative effect of Lotte Probiotic Chocolat® on loperamide-induced constipation in rats
Sungkeum Seo, Lotte R&D Center

16 – The market for vaginal probiotics for treatment of women with bacterial vaginosis in a region with high HIV and BV prevalence rates
Anna-Ursula Happel, University of Cape Town

17 – Screening of a Lactobacillus strain collection for the development of novel probiotics targeting the early prevention of chronic inflammatory diseases
Dr Delphine Saulnier and Dr Thomas Polakowski, Organobalance

18 – Searching for evidence to move science to claims: A new paradigm for study design
Najla Guthrie, KGK Science